For more than 40 years of continuous development, the company has specialized in the manufacture of pharmaceutical products including antibiotics, chemical synthesis materials, solid oral dosage forms and eye ointments.

The company's main products include Minocycline Hydrochloride and spiramycin tablets. It has a capacity to produce 2 billion tablets and 3 million freeze-dried powder injections annually. The company's marketing network covers 23 provinces, cities and autonomous regions nationwide. Its products are exported to countries and regions such as South Africa, Southeast Asia, Japan and the European Union.